RayKnowChina Research Map
Shortlist

Tianjin

TEDA International Cardiovascular Hospital

泰达国际心血管病医院

Listed for 2 of the 61 diseases this site covers, from the research papers it led and the trials registered with it as lead sponsor or site.

Research activity in public records, not a rating of care. Whether the hospital can help a particular patient is for the hospital and the treating doctor to say.

No official website checked for this hospital yet.

Getting in touch

Research at TEDA International Cardiovascular Hospital

Choose a disease to see the papers and trials behind it. Each tile shows papers led, 2021–2025, and papers per year.

Only the 61 diseases this site covers. A disease it is not listed for means this hospital did not meet the listing rule for that disease in these records; it does not mean the hospital does not treat it. Which hospitals are listed

  1. Coronary heart disease冠心病7 papers led
  2. Congenital heart disease先天性心脏病15 papers led

Not listed for: Nasopharyngeal carcinoma, Oesophageal squamous cell carcinoma, Hepatocellular carcinoma, Stomach cancer, Lung cancer, Pancreatic cancer, Breast cancer, Glioma, Hepatoblastoma, Retinoblastoma, Chordoma, Osteosarcoma, Gastrointestinal stromal tumour, Neuroblastoma, Ewing sarcoma, Multiple myeloma, B-cell acute lymphoblastic leukaemia, Aplastic anaemia, Haemophagocytic lymphohistiocytosis, Lymphoma, Beta thalassaemia, Haemophilia A, Atypical haemolytic uraemic syndrome, Thrombotic thrombocytopenic purpura, Fanconi anaemia, Neuromyelitis optica spectrum disorder, IgG4-related disease, Myasthenia gravis, Moyamoya disease, Wilson disease, Biliary atresia, Scoliosis, Anti-NMDA receptor encephalitis, Takayasu arteritis, Hepatic echinococcosis, Idiopathic pulmonary fibrosis, Lymphangioleiomyomatosis, Amyotrophic lateral sclerosis, Spinal muscular atrophy, Fabry disease, Pompe disease, Duchenne muscular dystrophy, Behçet disease, Alport syndrome, IgA nephropathy, Gaucher disease, Niemann–Pick disease type C, Osteogenesis imperfecta, Primary biliary cholangitis, Primary sclerosing cholangitis, Congenital diaphragmatic hernia, Hirschsprung disease, Inherited epidermolysis bullosa, Hereditary angioedema, Familial adenomatous polyposis, Leber hereditary optic neuropathy, Majeed syndrome, NGLY1 deficiency, ISG15 deficiency.

Other diseases

Coronary heart disease

冠心病

Led 7 of the 5,119 English-language PubMed papers on coronary heart disease with an author in mainland China, 2021–2025: 0.1%.

Papers led
7
2021–2025
Trials led
1
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 1120212022: 1120222023: 1120232024: 2220242025: 222025

9 hospitals in Tianjin for coronary heart disease231 hospitals in China for coronary heart disease

No open trial on coronary heart disease lists this hospital on ClinicalTrials.gov on 18 Nov 2026.

The records behind these numbers
Departments in papersPathology / laboratory medicine

Hospital name read automatically from author addresses, not yet checked by hand.

Papers it led7
  1. Evaluation of the clinical value of CCTA as the preferred screening method in patients with chronic coronary syndrome.2025BMC cardiovascular disordersRCTFree full text
  2. A New Method for Antispastic Effect in Coronary Artery Bypass Grafts by Using a L- and T-Type Calcium Channel Blocker Efonidipine.2025Basic & clinical pharmacology & toxicology
  3. Risk Factors of Postoperative Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery in the Recent 10 Years: Clinical Analysis of 6229 Patients.2024Clinical cardiologyFree full text
  4. The Characteristics of Coronary Artery Lesions in COVID-19 Infected Patients With Coronary Artery Disease: An Optical Coherence Tomography Study.2024The American journal of cardiology
  5. Comparison of in-hospital outcomes after coronary artery bypass graft surgery in elders and younger patients: a multicenter retrospective study.2023Journal of cardiothoracic surgeryFree full text
  6. Targeting IRE1α-JNK-c-Jun/AP-1-sEH Signaling Pathway Improves Myocardial and Coronary Endothelial Function Following Global Myocardial Ischemia/Reperfusion.2022International journal of medical sciencesFree full text
  7. Preoperative plasma biomarkers associated with atrial fibrillation after coronary artery bypass surgery.2021The Journal of thoracic and cardiovascular surgery
Chinese-language papers (not in the count)1
  1. [The relationship between NHR and coronary artery stenosis ≥50% in patients with controlled LDL-C].2025Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
All its trials on ClinicalTrials.gov, any status2
  1. Evaluate the Clinical Efficacy and Safety of Non-Compliant PTCA Balloon Dilatation CatheterCompletedNCT07855003Lead sponsorStart 2026-07
  2. International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)CompletedNCT01471522Study siteN/AStart 2012-07

Run the PubMed searchClinicalTrials.gov

Other diseases

Congenital heart disease

先天性心脏病

Led 15 of the 2,604 English-language PubMed papers on congenital heart disease with an author in mainland China, 2021–2025: 0.6%.

Papers led
15
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 1120212022: 6620222023: 2220232024: 3320242025: 332025

6 hospitals in Tianjin for congenital heart disease207 hospitals in China for congenital heart disease

No open trial on congenital heart disease lists this hospital on ClinicalTrials.gov on 18 Nov 2026.

The records behind these numbers

Hospital name read automatically from author addresses, not yet checked by hand.

Papers it led15
  1. Identification and pathological significance of variants in the promoter region of ACTC1 gene in congenital ventricular septal defect.2025Gene
  2. Molecular and cellular role of variants of the promoter region of HAND1 gene in sporadic and isolated ventricular septal defect.2025Molecular and cellular biochemistry
  3. Identification and functional validation of variants in the promoter region of HAND1 gene in sporadic tetralogy of Fallot.2025Pediatric research
  4. Functional FOXC1 variants in familial and sporadic atrial septal defect with cellular and animal validation.2024Clinical and translational medicineFree full text
  5. Variants of the promoter of MYH6 gene in congenital isolated and sporadic patent ductus arteriosus: case-control study and cellular functional analyses.2024Human molecular genetics
  6. Tetralogy of Fallot: variants of MYH6 gene promoter and cellular functional analyses.2024Pediatric research
  7. Genetic Variants of ISL1 Gene Promoter Identified from Congenital Tetralogy of Fallot Patients Alter Cellular Function Forming Disease Basis.2023BiomoleculesFree full text
  8. Identification and Functional Verification of CITED2 Gene Promoter Region in Patients with Patent Ductus Arteriosus.2023International journal of molecular sciencesFree full text
  9. Functional significance of novel variants of the MEF2C gene promoter in congenital ventricular septal defects.2022American journal of medical genetics. Part A
  10. Effect of CPB glucose levels on inflammatory response after pediatric cardiac surgery.2022BMC cardiovascular disordersFree full text
  11. Identification and functional analysis of variants of MYH6 gene promoter in isolated ventricular septal defects.2022BMC medical genomicsFree full text
  12. Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification.2022BiomoleculesFree full text
  13. Identification of novel rare copy number variants associated with sporadic tetralogy of Fallot and clinical implications.2022Clinical genetics
  14. Identification and functional analysis of genetic variants of ISL1 gene promoter in human atrial septal defects.2022The journal of gene medicine
  15. Identification of variants of ISL1 gene promoter and cellular functions in isolated ventricular septal defects.2021American journal of physiology. Cell physiology

Run the PubMed searchClinicalTrials.gov

Getting in touch

Name card to show staff or a driver

泰达国际心血管病医院

TEDA International Cardiovascular Hospital

天津

Large hospitals often have several campuses. Confirm the campus with the hospital before travelling.

Inquiry letter in English and Chinese

Fill in the brackets, then send it through the contact options on the hospital's international office or official website. Nothing typed here leaves this device.

Records hospitals usually ask for

  • A recent summary or letter from the treating doctor
  • Pathology report
  • Scans (CT, MRI, PET) with their reports, and the images if possible
  • Treatments so far, with dates
  • Current medicines

What to do next

Talk with the treating doctorThis page can be shared with the treating doctor to discuss whether this team's work is relevant.
Check the team is still therePapers lag by months and doctors move. Look for the department on the hospital's own website.
Contact the hospital directlyUse the hospital's own contacts. Hospitals never pay us, and each hospital decides which patients it accepts.

Where these numbers come from

Papers

English-language PubMed papers whose first or last author lists this hospital as their first affiliation, 2021–2025. Definitions

Trials

ClinicalTrials.gov records naming this hospital as lead sponsor or site, as of 8 Nov 2026.

Identifiers and other names

ROR Wikidata

Suggest a correctionDownload the data